Send a text

In this episode, Dr. Kevin White sits down with Dr. David Short to talk about something that’s shaking up the mental health world—psychedelics. We’re not talking about a Woodstock-style free-for-all, but the controlled, science-backed use of ketamine and psilocybin to help people break free from anxiety, depression, and the limits of traditional talk therapy.

Kevin and David dive into how these substances rewire the brain (hello, neuroplasticity!), why integration is key for lasting change, and real-life success stories of people who’ve found new clarity and purpose. They also take a hard look at why conventional therapy alone often falls short and what the future holds for psychedelic-assisted treatment.

If you’re curious about the science, the breakthroughs, or just whether these treatments are more than just trippy hype—this conversation is for you. Tune in and get ready to expand your mind (without actually leaving your couch).

You can learn more at Dr. Short's website, www.findthecenter.love or follow him on Instagram

takeaways

• Psychedelics like ketamine and psilocybin are changing mental health treatment.
• Traditional talk therapy has limitations that psychedelics can address.
• Integration is crucial for sustainable change after psychedelic therapy.
• Psychedelics can help access deeper parts of the psyche.
• The default mode network plays a significant role in depression.
• Neuroplasticity is essential for breaking old patterns of thought.
• Clients often experience profound personal growth through this work.
• There is a need for a right relationship with psychedelics.
• Psychedelic therapy requires active participation from clients.
• Holistic approaches to mental health are essential for overall well-being.

Prime Health Associates